Amgen Announces $5 Billion Buyback; Move Reinforces Our 'Undervalued" Thesis
publication date: Nov 7, 2011
Amgen announced that it will purchase $5 billion worth of its common stock under a modified Dutch auction. We think the move reinforces our valuation thesis on the biotech firm.
To gain access to the members only content, click here to subscribe. You will be given immediate access to premium content on the site.